Long-term cardiac, vascular and hypertensive safety of bosutinib in patients with Philadelphia chromosome-positive (Ph+) leukemia resistant or intolerant to prior therapy Meeting Abstract


Authors: Cortes, J. E.; Kim, D. W.; Kantarjian, H. M.; Mauro, M. J.; Aguiar, J. M.; An, F.; Leip, E.; Gambacorti-Passerini, C.; Brummendorf, T. H.
Abstract Title: Long-term cardiac, vascular and hypertensive safety of bosutinib in patients with Philadelphia chromosome-positive (Ph+) leukemia resistant or intolerant to prior therapy
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419404034
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.1590.1590
Notes: Meeting Abstract: 1590 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro